Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Berkowitz

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
Epilepsy & Behavior : E&B|December 8, 2004
Developing a measure to assess attitudes toward epilepsy in the US populationColleen A Diiorio, Rosemarie Kobau, E Wayne Holden, et al.
European Journal of Haematology|July 12, 2024
The impact of hematology electronic consultations on the management of iron deficiencyHannah L King, Genevieve B Benedetti, Stefan Barisic, et al.
Respiration; International Review of Thoracic Diseases|April 13, 2021
Variable Learning Curve of Basic Rigid Bronchoscopy in TraineesKamran Mahmood, Momen M Wahidi, Ray Wes Shepherd, et al.
Blood|September 20, 2014
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipientsEdward A Stadtmauer, Keith M Sullivan, Francisco M Marty, et al.
Lancet (London, England)|December 27, 2014
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trialHannah Kibuuka, Nina M Berkowitz, Monica Millard, et al.
The New England Journal of Medicine|November 27, 2014
Chimpanzee Adenovirus Vector Ebola VaccineJulie E Ledgerwood, Adam D DeZure, Daphne A Stanley, et al.
The Lancet. Respiratory Medicine|April 17, 2021
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trialTracy J Ruckwardt, Kaitlyn M Morabito, Emily Phung, et al.
Science (New York, N.Y.)|August 3, 2019
A proof of concept for structure-based vaccine design targeting RSV in humansMichelle C Crank, Tracy J Ruckwardt, Man Chen, et al.
The New England Journal of Medicine|August 11, 2021
A Monoclonal Antibody for Malaria PreventionMartin R Gaudinski, Nina M Berkowitz, Azza H Idris, et al.
Immunity|April 6, 2021
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responsesMaryam Mukhamedova, Daniel Wrapp, Chen-Hsiang Shen, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Epilepsy & Behavior : E&B|December 8, 2004
Developing a measure to assess attitudes toward epilepsy in the US populationColleen A Diiorio, Rosemarie Kobau, E Wayne Holden, et al.
European Journal of Haematology|July 12, 2024
The impact of hematology electronic consultations on the management of iron deficiencyHannah L King, Genevieve B Benedetti, Stefan Barisic, et al.
Respiration; International Review of Thoracic Diseases|April 13, 2021
Variable Learning Curve of Basic Rigid Bronchoscopy in TraineesKamran Mahmood, Momen M Wahidi, Ray Wes Shepherd, et al.
Blood|September 20, 2014
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipientsEdward A Stadtmauer, Keith M Sullivan, Francisco M Marty, et al.
Lancet (London, England)|December 27, 2014
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trialHannah Kibuuka, Nina M Berkowitz, Monica Millard, et al.
The New England Journal of Medicine|November 27, 2014
Chimpanzee Adenovirus Vector Ebola VaccineJulie E Ledgerwood, Adam D DeZure, Daphne A Stanley, et al.
The Lancet. Respiratory Medicine|April 17, 2021
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trialTracy J Ruckwardt, Kaitlyn M Morabito, Emily Phung, et al.
Science (New York, N.Y.)|August 3, 2019
A proof of concept for structure-based vaccine design targeting RSV in humansMichelle C Crank, Tracy J Ruckwardt, Man Chen, et al.
The New England Journal of Medicine|August 11, 2021
A Monoclonal Antibody for Malaria PreventionMartin R Gaudinski, Nina M Berkowitz, Azza H Idris, et al.
Immunity|April 6, 2021
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responsesMaryam Mukhamedova, Daniel Wrapp, Chen-Hsiang Shen, et al.
Pageof 18